Similarly, several cancers are deficient for the urea cycle enzyme, argininosuccinate synthase (ASS1), which appears to be a metabolic advantage by diverting aspartate into de novo pyrimidine synthesis [75], but renders ASS1-deficient cancer cells auxotrophic for arginine [76]. This evidence concerns the gene ASS1 and cancer.